Charles River Laboratories International Inc. (CRL) Stock

Valuation data is not available for this stock.

With a beta of 1.47, Charles River Laboratories International Inc. is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 2.18 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Charles River Laboratories International Inc. achieves a profit margin of -1.66%, meaning it retains $-1.66 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 16.70% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -1.81% and ROA at 4.31%, the company achieves moderate returns on invested capital.

Charles River Laboratories International Inc.'s revenue grew by 0.60% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings decreased by 39.10% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against DIAGNOSTICS & RESEARCH industry averages for proper context.

Charles River Laboratories International Inc. has a market capitalization of $7.3B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 49.21M shares outstanding, the company's ownership is relatively concentrated. As a participant in the DIAGNOSTICS & RESEARCH industry, it competes with other firms in this sector.

Charles River Laboratories International Inc.'s book value per share is $68.14, while the current stock price is $179.08, resulting in a price-to-book (P/B) ratio of 2.63. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

18 analysts cover CRL with 33% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $177.73 implies -0.8% downside, but targets are often adjusted to follow price moves rather than predict them.

Current analyst recommendations:1 Strong Buy, 5 Buy, 12 Hold, 00The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.